Vascular Graft Market

Industry Overview

The Global Vascular Grafts Market size is expected to grow from USD 1.7 billion in 2023 to USD 2.8 billion by 2030 at a compound annual growth rate (CAGR) of 7.2% during the projected period ranging from 2025 to 2030.

A vascular graft refers to a synthetic tube or biological conduit. It is mainly used in vascular surgery and to cover diseased or injured areas of veins and arteries to redirect blood flow and restore normalcy. In surgical procedures, a vascular graft is typically used for bypassing or replacing damaged blood vessels. Usually made from materials like materials like Dacron (polyester) or PTFE (polytetrafluoroethylene), these vascular grafts can also be made from human or animal tissues. The primary purpose of using them is to restore conditions such as arterial blockages or aneurysms to prevent complications and improve circulation.

The global vascular graft market is growing rapidly due to the significant rise in the geriatric population and the increasing prevalence of diabetes and cardiovascular diseases such as peripheral artery disease (PAD), coronary artery disease (CAD), chronic kidney disease (CKD), and aneurysms. It is also attributed to the growing prevalence of smoking as well as the increasing demand for minimally invasive surgical procedures. In addition, the rising healthcare expenditure, accessibility of reimbursement policies, and technological development propel the growth of the market further.

The product failure and recall as well as the high cost of treatment along with less product differentiation which leads to competition among the existing players are the major challenges for the growth of vascular graft market. However, major growth opportunities are presented to the market due to rapid technological advancements and innovations in materials and manufacturing techniques. This results in higher biocompatibility and durability of the grafts and reduces complications.

Market Segmentation

Insight by Raw Material

The global vascular graft market is divided by raw material into polyurethane grafts, polyester grafts, ePTFE grafts, and biosynthetic grafts. Out of these segments, the polyester graft segment is expected to hold the largest market share due to high demand, more benefits, greater lifespan, and absorbency.

Insight by Indication

The global vascular graft market is also categorized by indication into hemodialysis access, endovascular aneurysm repair (EVAR), and peripheral vascular repair. Out of them, the endovascular aneurysm repair segment will contribute more due to the growing geriatric population, growing preference, and higher acceptance.

Insight by End-User

The different end users also divide the global vascular graft market into hospitals and ambulatory surgical centers, where the former will hold the largest share and grow faster due to favorable reimbursement policies in the developed countries, increasing the prevalence of ESRD and cardiovascular diseases resulting in higher adoption.

Insight by Product

The global vascular graft market is divided by-products into hemodialysis access grafts, endovascular stent grafts, coronary artery bypass grafts, vascular grafts for aorta disease, and peripheral vascular grafts. Out of these segments, the endovascular stent grafts segment will lead the market due to wide applicability in various conditions and higher effectiveness. In addition, the peripheral vascular grafts segment will also grow at a high CAGR due to the higher prevalence of peripheral vascular diseases (PVD).

Insight by Application

The global vascular graft market is divided by application into cardiac aneurysm, endovascular stent graft, vascular graft, kidney failure, vascular occlusion, and coronary artery disease segments. Out of them, the cardiac aneurysm segment will contribute higher market revenue due to the higher prevalence of such disorders among individuals. In addition, the vascular occlusion segment will also grow at a higher CAGR due to the increasing incidence of vascular occlusive diseases.

Global Vascular Graft Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D.  xx.x Billion
Revenue Forecast in 2030	U.S.D.  xx.x Billion
Growth Rate	x.x%
Segments Covered in the Report	By Raw Material, By Indication and By End-User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Middle East, South America and Rest of the World

Industry Dynamics

Industry Trends

One of the major trends of the vascular graft market is the rapid development of biosynthetic vascular grafts and the higher demand and growing acceptance for them due to exceptional re-infection resistance and biocompatibility. There is also a rapid transformation noticed in the regional landscape within the vascular grafts sector since the major players are trying to enter new markets and capitalize on the available opportunities. In addition to the key market players, the researchers are also actively engaged in research and development to come up with innovative vascular grafts to cater to the diverse essential requirements.

Growth Drivers

Higher adoption of specific processes such as the MIDCAB procedure is the primary growth factor of the global vascular graft market. In addition, the higher safety and assurance of a low mortality rate also fuels the market growth. Furthermore, the compatibility of these grafts with aortic cross-clamp and cardiopulmonary bypass, advancements in surgical techniques of coronary artery stent grafts, the widespread use of prosthetic grafts such as electro-spun polyurethane vascular grafts for complex vascular trauma, the ability to reduce the risk of neointimal formation, rising prevalence of diabetes, and higher occurrence of end-stage renal disease (ESRD) are also fueling the growth of the vascular graft industry.

Challenges

The most significant factor that hinders the widespread expansion of the global vascular graft market is the risk of infection and complications involved in the process including interruption of infected anastomotic rigid line, sepsis, and even amputation. In addition, the capital intensity as well as the highly regulated vascular graft market prevents new entries, thereby preventing the market expansion.

Opportunities

The market growth opportunities however lie in the growing incidents of cardiovascular diseases and disorders which demand vascular grafts for treatments. The growing aging populations prone to vascular conditions, the developing markets with improving healthcare infrastructure, and the development of bioengineered vascular grafts utilizing tissue engineering and regenerative medicine approaches offer new growth possibilities.

Geographic Overview

North America geographically is the largest contributor to the vascular graft market due to rising healthcare expenditure, growing occurrence of diabetes, higher government initiatives, and growing research and development. It is also attributed to the increasing geriatric population, growing prevalence of ESRD and cardiovascular disease, and higher adoption of minimally invasive surgeries.

The Asia-Pacific market will grow at a fast pace during the forecast period due to the large population, improved healthcare infrastructure, growing geriatric population, growth in the number of smokers, growth in medical tourism, and higher adoption of minimally invasive procedures.

Competitive Insight

Key players in the vascular graft industry are investing in the development of innovative and advanced graft products, which is strengthening their position in the market. 

Medtronic Plc, Terumo Corporation, Maquet, C. R. Bard, B. Braun Melsungen AG, Lemaitre Vascular, Cardinal Health, Endologix, Cook Medical Inc., and W.L. Gore & Associates Inc., are some of the key players offering vascular graft products.

Medtronic plc is an American-Irish medical device company. The company's operational and executive headquarters are in Minneapolis, Minnesota. Medtronic manufactures catheters, stents, and accessories for cardiovascular products.

Terumo Aortic is the group's vascular business, providing products including surgical grafts and stent-grafts that are used by surgeons.

Recent Developments by Key Players

Cardinal Health acquired Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organization for UDS 1.2B in cash. Specialty Networks create clinical and economic value for independent specialty providers and partners across multiple specialty GPOs that are UroGPO, Gastrologix and GastroGPO, and United Rheumatology.

Getinge and Cook Medical announced an agreement for the iCast-covered stent system.

The Vascular Graft Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.

Segments Covered in the Report

• By Raw Material
  • Polyurethane grafts
  • Polyester grafts
  • ePTFE grafts
  • Biosynthetic grafts
• By Indication
  • Hemodialysis access
  • Endovascular aneurysm repair (EVAR)
  • Peripheral vascular repair
• By End-User
  • Hospitals
  • Ambulatory surgical centers

Geographical Segmentation

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries

Source: VynZ Research

Source: VynZ Research